Edition:
United States

SAGE Therapeutics Inc (SAGE.OQ)

SAGE.OQ on NASDAQ Stock Exchange Global Market

168.56USD
20 Jul 2018
Change (% chg)

$-0.06 (-0.04%)
Prev Close
$168.62
Open
$168.78
Day's High
$171.91
Day's Low
$168.20
Volume
109,235
Avg. Vol
190,363
52-wk High
$195.97
52-wk Low
$59.59

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -1.683
FY 2017 Dec '17 0.00 -1.720
Sep '17 0.00 -1.967
Jun '17 0.00 -1.879
Mar '17 0.00 -1.523
FY 2016 Dec '16 0.00 -1.498
Sep '16 0.00 -1.146
Jun '16 0.00 -1.084
Mar '16 0.00 -0.965
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 11 0.00 0.00 0.00 13.60
Quarter Ending Dec-18 11 9.44 103.86 0.00 19.44
Year Ending Dec-18 13 14.91 103.86 0.00 41.73
Year Ending Dec-19 12 58.00 155.78 12.20 244.83
Earnings (per share)
Quarter Ending Sep-18 12 -2.16 -1.48 -2.79 -1.47
Quarter Ending Dec-18 12 -2.47 -0.50 -4.27 -1.37
Year Ending Dec-18 12 -8.15 -5.92 -10.62 -6.00
Year Ending Dec-19 11 -8.52 -5.24 -12.39 -2.27
LT Growth Rate (%) 1 -15.40 -15.40 -15.40 -2.20
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 214.53 33.05
P/E High - Last 5 Yrs. -- 284.38 47.17
P/E Low - Last 5 Yrs. -- 96.91 24.95
Beta 3.01 0.76 0.81
Price to Sales (TTM) -- 254.39 8.10
Price to Book (MRQ) 7.40 21.00 4.20
Price to Tangible Book (MRQ) 7.38 27.24 6.22
Price to Cash Flow (TTM) -- 130.02 22.23
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.74
Dividend Yield - 5 Year Avg -- 0.21 1.46
Dividend 5 Year Growth Rate -- 2.25 -6.34
Payout Ratio(TTM) -- 83.66 47.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 33.06 4.76
Sales (TTM) vs TTM 1 Yr. Ago -- 147.32 12.20
Sales - 5 Yr. Growth Rate -- 30.74 7.68
EPS (MRQ) vs Qtr. 1 Yr. Ago -10.47 -78.41 49.25
EPS (TTM) vs TTM 1 Yr. Ago -38.05 -- --
EPS - 5 Yr. Growth Rate -- 46.75 7.98
Capital Spending - 5 Yr. Growth Rate 65.06 42.59 7.61

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.72 2.56
Current Ratio (MRQ) 28.92 6.63 3.63
LT Debt to Equity (MRQ) 0.00 24.37 13.18
Total Debt to Equity (MRQ) 0.00 28.57 17.32
Interest Coverage (TTM) -- -156.06 35.18

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.96 55.27
Gross Margin - 5 Yr. Avg. -- 53.49 53.21
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -180.79 15.63
Operating Margin (TTM) -- -952.42 -0.59
Operating Margin - 5 Yr. Avg. -- -194.47 10.78
Pre-Tax Margin (TTM) -- -846.49 1.29
Pre-Tax Margin - 5 Yr. Avg. -- -199.31 10.90
Net Profit Margin (TTM) -- -837.92 -2.01
Net Profit Margin - 5 Yr. Avg. -- -197.08 7.26
Effective Tax Rate (TTM) -- 14.85 20.80
Effective Tax Rate - 5 Yr. Avg. -- 19.02 24.29

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 23,390,416 736,883,287
Net Income/Employee (TTM) -1,120,393 -1,131,911 85,936,826
Receivable Turnover (TTM) -- 17.85 5.95
Inventory Turnover (TTM) -- 2.85 3.69
Asset Turnover (TTM) 0.00 0.48 0.87

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -39.67 -2.22 10.35
Return on Assets - 5 Yr. Avg. -57.67 2.95 11.02
Return on Investment (TTM) -41.67 -3.67 13.17
Return on Investment - 5 Yr. Avg. -63.20 2.77 14.24
Return on Equity (TTM) -41.80 -5.61 15.10
Return on Equity - 5 Yr. Avg. -66.93 -4.39 15.57
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -49.30 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for SAGE Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 351
Total Shares Held: 47,620,113
3 Mo. Net Change: 19,850
# New Positions: 10
# Closed Positions: 1
# Increased Positions: 26
# Reduced Positions: 17
# Net Buyers: 9
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.